60 Degrees Pharmaceuticals, Inc.
SXTPW· Nasdaq
SXTPW60 Degrees Pharmaceuticals, Inc.
Filed Aug 25, 2023 · 10-Q · 56 days after period end · 0001213900-23-070884
| Metric | Q2 2023 | Q2 2022 |
|---|---|---|
| Revenue | $59.53K | $45.17K |
| Net Income | -$3.34M | -$2.15M |
| EPS Diluted | -$16.84 | -$0.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 25, 2023 · 56 d after period end
